NCT00201942View on ClinicalTrials.gov

PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)

PHASE3CompletedINTERVENTIONAL
Enrollment

336

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

May 31, 2007

Conditions
Breast Cancer
Interventions
PROCEDURE

PET scan

Trial Locations (10)

L8N 4A6

St. Joseph's, Hamilton

L8V 1C3

Juravinski Cancer Centre, Hamilton

K7L 5P9

Kingston Regional Cancer Centre, Kingston

N6A 4L6

London Regional Cancer Centre, London

K1Y 4K7

Ottawa Regional Cancer Centre, Ottawa

M2J 1V1

North York, Toronto

M4N 3M5

Sunnybrook Regional Cancer Centre and Women's College, Toronto

M5B 1W8

St. Michael's, Toronto

M5G 1X5

Mount Sinai Hospital, Toronto

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

Ontario Ministry of Health and Long Term Care

OTHER_GOV

lead

Ontario Clinical Oncology Group (OCOG)

OTHER

NCT00201942 - PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial) | Biotech Hunter | Biotech Hunter